ArticleScientific reports2022

The third-generation anti-CD30 CAR T-cells specifically homing to the tumor and mediating powerful antitumor activity.

Shangkun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.